An #IEEE technical community facilitating cross-disciplinary collaboration to advance research, standardization & development of #neuroscience technologies.
We're now moving into audience Q&A, so we'll take this opportunity to thank our moderator and panelists, and everyone attending today's #webinar. #Neurotech's role in #AgeTech is critical and this has been a great discussion. Stay tuned for the on-demand replay! #brain
Dr. Dan Rizzo of @NiaTherapeutics has a different take - the biggest thing #AI does to compress the timeline. It can extract signal from noise more efficiently, potentially helping therapies to reach patients faster. However, he notes the best AI is boring AI, that is invisible.
What of #AI? How are advances in #AI changing the field? What needs to happen for AI's use to be clinically useful, #ethical, and safe? According to #EpiaNeuro's Dr. Michel Maharbiz, regulatory and security concerns can have a big impact. #brain#neurotech#AgeTech
What are some of the key #neuroethical aspects that must be taken into account before getting a #brain implant? @penn_states' Laura Cabrera says timing is critical, and you must find a window where the devices is still beneficial but where the patient can still undergo surgery.
#EpiaNeuro's Dr. Michel Maharbiz, one outstanding issue in invasive #neurotech is the lifetime of these devices. While there is the impression that these devices might last a lifetime, that may not always be the case. Communication is absolutely key. #brain#AgeTech#aging
A great question: what are the biggest barriers to translating new technologies into long-term therapies for patients? @NiaTherapeutics' Dr. Dan Rizzo notes that #regulatory hurdles can be big bar, as is reimbursement. #brain#neurotech#BCI#AgeTech
What of the broader societal implications? @penn_state's Laura Cabrera notes that there has been a trend to look at #aging as a disease. That reclassification could significantly impact #medicine. #brain#neurotech
Our next panelist is @penn_state's Laura Cabrera, who is talking about some of the technology-based solutions to help patients but more importantly, the #ethics implications of these technologies, including #privacy, #security, and invasiveness. #brain#neurotech
What is the scale of the issue of #strokes? According to #EpiaNeuro's Dr. Michael Maharbiz, it's enormous. And there's currently no good solution to the problem...something that researchers are now trying to change. #brain#neurotech
We're now hearing from #EpiaNeuro's Dr. Michael Maharbiz, who is addressing the human impact of strokes - specifically, what happens when a person suffers a #stroke. The recovery journey can be a long one, leaving patients to live with with the affects. #brain#neurotech
How well does #neurostimulation work for those suffering from memory loss? Here's a look at the results that @NiaTherapeutics has achieved thus far, noting that it can possibly roll back 4 or 5 years for #Alzheimers patients. #neurotech#brain
Our first speaker is Dr. Dan Rizzuto of @NiaTherapeutics. He notes that memory loss is a thief that steals independence from some 27M people. However, #neurostimulation therapies can help restore memory. #neurotech#aging
Do you know which are the top five neurological disorders? @UCBerkeley's Rikky Muller has a look at which conditions are most prevalent, with diabetic neuropathy being most common. #brain#neurotech
Our moderator today is Rikky Muller of @UCBerkeley, who is providing an introduction to both @IEEEBrain and #IEEEAgeTech, and offering an overview of what we'll be hearing about in today's presentation. #brain#neurotech